Capsulotomy Adoption Underpinned by Nd: YAG Laser Surgery Deployment

High incidence of post-cataract surgical complications is augmenting the demand for advanced high speed post-surgery correction procedures

High incidence of post-cataract surgical complications is augmenting the demand for advanced high speed post-surgery correction procedures

Fact.MR, Rockville MD: Award winning consulting firm Fact.MR is conducting an extensive study on the global capsulotomy market. According to the study, the market is expected to post significant gains through 2021, as ophthalmic surgical procedures resume in the post-coronavirus pandemic scenario. Long-term prospects are poised to remain elevated.

As per statistics provided by the World Health Organization, presently, over 2 billion people across the world suffer from near or distance vision impairment, with at least 50% of them being preventable. Of the 1 billion people suffering from acute visual impairments, cataract affects 94 million (9.4%) of the patient pool. Consequently, healthcare providers are actively leveraging anti-cataract surgical solutions.

Key solutions providers are exploiting Nd: YAG (Neodymium-doped Yttrium Aluminium Garnet) laser technologies to provide enhanced care. Players such as ASTANZA and SpaMedica are some prominent faces offering this technology on a commercial scale. The latter offers treatment for posterior capsule opacification (PCO), the most common cataract surgery complication, capable of correcting the defect within 30 to 60 seconds.

“As the global geriatric population expands, prevalence of visual impairments is rising, prompting increased number of surgeries, ultimately enhancing growth prospects for prominent capsulotomy service providers in the long run,” comments a Fact.MR analyst.

For more insights into the Market, Request a Sample of this Report https://www.factmr.com/connectus/sample?flag=S&rep_id=3982

Key Takeaways from Fact.MR’s Capsulotomy Market Study

  • By product type, mobile capsulotomy systems are generating high demand amid rising need for flexibility
  • By technology, thermal capsulotomy systems deployment is expected to accelerate as it results in less IOL tilt
  • Anterior capsulotomy procedures are expected to witness a credible incline through 2021
  • Eye care centers to emerge as primary centers for seeking advanced capsulotomy treatment
  • US to experience credible growth, amid growing prevalence of cataract surgeries
  • UK to emerge as a promising market, attributed to efforts in bolstering ophthalmology care infrastructure as part of UK Vision Strategy 2020
  • High rates of dry eyes and myopia to fuel capsulotomy procedures across Germany & France
  • India and China to experience increased uptake amid growing efforts to offer low-cost eye care

Capsulotomy Market- Prominent Drivers

  • High incidence of cataract is fueling corrective surgeries, heightening capsulotomy growth prospects
  • Key players are incorporating advanced laser correction technologies to reduce eye trauma
  • Capsulotomy systems providers are largely benefitting from wider healthcare budgetary allocations to promote affordable eye care

Capsulotomy Market- Key Restraints

  • Documented side-effects such as nerve layer detachment in the rear parts of the eye to hinder adoption
  • Asymmetrical access to quality healthcare in developing regions is limiting capsulotomy systems sales

Discover more about the capsulotomy market with figures, data tables and the table of contents. You will also find detailed market segmentation on https://www.factmr.com/report/3982/capsulotomy-market

Competitive Landscape

Prominent players operating in the global capsulotomy market are Mynosys Cellular Devices, Inc., International BioMedical Devices Inc., EXCEL-LENS, Inc., Optotek Medical, Carl Zeiss Meditec AG, Ellex Medical Lasers and Lumenis Ltd. among others. Key expansion strategies include product launches, acquisitions, partnerships and collaborations. The aforementioned strategies have helped manufacturers establish a firm footprint.

In October 2019, Mynosys Cellular Devices Inc. raised a sum of US$ 25 million for its Zepto cataract device to further enhance its capability of achieving precision pulse capsulotomy in challenging cataract surgery cases. The financing was undertaken with a view to strengthen R&D capacities, manufacturing of the device and commercial organization.

Likewise, Ellex Medical Lasers offers a unique capsulotomy solution equipped with next generation YAG laser technology which minimizes shockwaves, optimizing precision. The procedure is highly useful in the sense that it helps achieve a perfectly centered and precise capsulotomy which does not affect the tension of the bag and the position of the intraocular lens in the visual axis.

More Insights on the Capsulotomy Market

In its latest report, Fact.MR offers unbiased analysis of the global capsulotomy market. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (fixed capsulotomy system and mobile capsulotomy system), technology (pulse capsulotomy systems, thermal capsulotomy systems and others), procedure type (anterior capsulotomy and posterior capsulotomy) and distributional sales (hospital, ambulatory surgical centers and eye care centers) across seven major regions (North America, Latin America, Europe, CIS & Russia, Japan, APEJ and Middle East & Africa).

Request more information about Report Methodology

https://www.factmr.com/connectus/sample?flag=RM&rep_id=3982

Explore Fact.MR’s Coverage on the Healthcare Domain

Controlled Substances Market: This Fact.MR study delivers a comprehensive analysis of the controlled substances market, along with a detailed & accurate forecast of the market. Key aspects affecting growth of the controlled substances market have been analyzed and their degree of impact on demand for controlled substances worldwide have been evaluated. The report further highlights macro- and micro-economic factors influencing growth.

Antiseptic Bathing Market: The antiseptic bathing market report compiled by Fact.MR elucidates on the prominent expansion dynamics expected to shape future growth trajectory. Market trends have been presented on the basis of key drivers and opportunities across key segments and prominent regions through the forthcoming decade. A detailed competitive landscape further enhances reliability of this study.

Dyslipidemia Therapeutics Market: The dyslipidemia therapeutics market research report compiled by Fact.MR elaborates on the prominent expansion dynamics for the upcoming decade. Details about prominent segments across key geographical locations have been embedded in the report, along with an in-depth analysis of the competitive landscape.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Follow Us: LinkedIn | Twitter
Market Intelligence Services: Marketngage
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Source: Fact.MR